article_metadata: Wulyo Rajabto Vitya Chandika Agnes Stephanie Harahap Maria Francisca Ham
article_metadata: 10.2147/IMCRJ.S348718
article_metadata: Int Med Case Rep J
article_metadata: 2022 Jun 1;15:269-273.
article_metadata: covid-19 brentuximab vedotin monotherapy refractory hodgkin’s lymphoma
article_metadata: CC BY-NC
article_metadata: https://pubmed.ncbi.nlm.nih.gov/35677855/
article_metadata: Case Reports
article_metadata: PMC9167837
article_metadata: 35677855
article_metadata: The Role of Brentuximab Vedotin (BV) as Second-Line Treatment of Refractory Classical Hodgkin Lymphoma (cHL) in the Era of Pandemic COVID-19
article_metadata: 2022